Bicara Therapeutics Inc. Common Stock (BCAX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Bicara Therapeutics Inc. ...

    NASDAQ: BCAX · Real-Time Price · USD
    17.04
    0.33 (1.97%)
    At close: Oct 03, 2025, 3:59 PM
    16.92
    -0.70%
    Pre-market: Oct 06, 2025, 04:04 AM EDT

    Bicara Therapeutics Common Stock Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
    Net Income
    		 -27.39M -36.85M -20.96M -17.48M -14.78M -14.78M -12.44M -22.84M -8.35M -8.35M
    Depreciation & Amortization
    		 19K 19K 15K 15K 13K 13K 14K 2K 1.5K 1.5K
    Stock-Based Compensation
    		 3.49M 3.45M 3.18M 2.03M 1.09M 1.09M 765K 519K 307.5K 307.5K
    Other Working Capital
    		 451K 3.97M -16.28M -180K -155.5K -155.5K 2.94M -1.56M -440K -440K
    Other Non-Cash Items
    		 211K 138K -276K 68K 920.5K -758.5K 681K 13.35M -5.05M -5.05M
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Change in Working Capital
    		 -1.93M 5.13M -11.99M -1.86M -155.5K -155.5K 2.94M -1.56M -440K -440K
    Operating Cash Flow
    		 -25.59M -28.11M -30.03M -17.22M -12.91M -14.59M -8.04M -10.53M -13.53M -13.53M
    Capital Expenditures
    		 n/a n/a -40K -8K -11.5K -11.5K -436K -150K n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a -7.5K 69.5K n/a n/a n/a n/a
    Investing Cash Flow
    		 n/a n/a -40K -8K -19K 58K -436K -150K n/a n/a
    Debt Repayment
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a 77K n/a n/a n/a n/a 84K 18.95M 18.95M
    Financial Cash Flow
    		 135K 460K -975K 334.13M 734K 137K 194.7M 39.9M 18.95M 18.95M
    Net Cash Flow
    		 -25.46M -27.65M -31.05M 316.9M 203.85M -14.39M 186.23M 29.22M 14.99M n/a
    Free Cash Flow
    		 -25.59M -28.11M -30.07M -17.23M -13.76M -13.76M -8.47M -10.68M -13.53M -13.53M

    Add to Watchlist